glp-1/gip dual agonist The glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Dual GLP-1/GIP Agonist | Tirzepatide

L-Carnitine deficiency causing hypoxic respiratory failure due to recurrent flash pulmonary edema

In a rat model of intervertebral disc degeneration, MOTS-c injection preserved disc height (82.4% versus 58.7% in the untreated group), restored MRI signals indicating improved disc hydration, and reduced histological degeneration scores by 44% compared to untreated controls

Because not only does all the signaling say, do something with the cholesterol, but the way you actually get cholesterol into the cell is to burn through a bunch of ATP with motor proteins, move it from outside the cell to inside the cell in order to facilitate that turnover

E.MatterE

Carcinogenesis 11 , 451458 (1990)